Literature DB >> 8512012

Serum adenosine deaminase activity in brain tumours.

S Manjula1, A Raja, S N Rao, A R Aroor, A Rao.   

Abstract

Adenosine deaminase (ADA) activity in serum was estimated in 86 patients with intracranial tumours and 40 healthy volunteers. Although high ADA concentrations in biological fluids and tumour tissues were observed in several neoplastic conditions, there was no significant difference in the ADA in sera of brain tumour patients when compared to the control values. Therefore, cell-mediated immunity probably does not play a significant role in brain tumours.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8512012     DOI： 10.1007/BF01809267

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN： 0001-6268            Impact factor:   2.216


  23 in total

1.  The deaminases of adenosine and adenylic acid in blood and tissues.

Authors:  E J Conway; R Cooke
Journal:  Biochem J       Date:  1939-04       Impact factor: 3.857

2.  [Use of the study of DNA metabolism enzyme activities as a test system in the treatment of breast cancer].

Authors:  B G Borzenko
Journal:  Sov Med       Date:  1991

3.  Adenosine deaminase activity in pleural effusions: an aid to differential diagnosis.

Authors:  M A Piras; C Gakis; M Budroni; G Andreoni
Journal:  Br Med J       Date:  1978 Dec 23-30

4.  Elevated erythrocyte adenosine deaminase activity in patients with acquired immunodeficiency syndrome.

Authors:  M J Cowan; R O Brady; K J Widder
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

Review 5.  Immunobiologic aspects of head and neck cancer. Clinical and laboratory correlates.

Authors:  D R Vlock
Journal:  Hematol Oncol Clin North Am       Date:  1991-08       Impact factor: 3.722

6.  [The enzymatic activity of DNA metabolism of the blood in patients operated on in stomach cancer].

Authors:  B G Borzenko; A A Gorbachev; Iu V Dumanskiĭ; V V Shevchenko
Journal:  Vopr Onkol       Date:  1989

7.  Quantitative changes in adenosine deaminase isoenzymes in human colorectal adenocarcinomas.

Authors:  J ten Kate; J T Wijnen; R G van der Goes; R Quadt; G Griffioen; F T Bosman; P M Khan
Journal:  Cancer Res       Date:  1984-10       Impact factor: 12.701

8.  Adenosine deaminase and purine phosphorylase activities in lymphocytes and red blood cells of patients with carcinoma of the larynx.

Authors:  T Gierek; M Drózdz; J Pilch; A Jendryczko; J Piekarska
Journal:  Auris Nasus Larynx       Date:  1987       Impact factor: 1.863

9.  Serum-mediated immunosuppression in lung cancer.

Authors:  A E Giuliano; D Rangel; S H Golub; E C Holmes; D L Morton
Journal:  Cancer       Date:  1979-03       Impact factor: 6.860

10.  Some biochemical mechanisms underlying the impairment of T and B cell immunity in C3HA mice during hepatoma growth.

Authors:  G I Potapova; S N Khramtsova; L V Dmitrieva; V S Shapot
Journal:  Neoplasma       Date:  1987       Impact factor: 2.575
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.